Lagreca, I.; Nasillo, V.; Barozzi, P.; Castelli, I.; Basso, S.; Castellano, S.; Paolini, A.; Maccaferri, M.; Colaci, E.; Vallerini, D.;
et al. Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies. Cancers 2023, 15, 972.
https://doi.org/10.3390/cancers15030972
AMA Style
Lagreca I, Nasillo V, Barozzi P, Castelli I, Basso S, Castellano S, Paolini A, Maccaferri M, Colaci E, Vallerini D,
et al. Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies. Cancers. 2023; 15(3):972.
https://doi.org/10.3390/cancers15030972
Chicago/Turabian Style
Lagreca, Ivana, Vincenzo Nasillo, Patrizia Barozzi, Ilaria Castelli, Sabrina Basso, Sara Castellano, Ambra Paolini, Monica Maccaferri, Elisabetta Colaci, Daniela Vallerini,
and et al. 2023. "Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies" Cancers 15, no. 3: 972.
https://doi.org/10.3390/cancers15030972
APA Style
Lagreca, I., Nasillo, V., Barozzi, P., Castelli, I., Basso, S., Castellano, S., Paolini, A., Maccaferri, M., Colaci, E., Vallerini, D., Natali, P., Debbia, D., Pirotti, T., Ottomano, A. M., Maffei, R., Bettelli, F., Giusti, D., Messerotti, A., Gilioli, A.,
... Riva, G.
(2023). Prognostic Relevance of Multi-Antigenic Myeloma-Specific T-Cell Assay in Patients with Monoclonal Gammopathies. Cancers, 15(3), 972.
https://doi.org/10.3390/cancers15030972
